Skip to Main Content
Table 4

Phosphorylation of pyrimidine and deoxycytidine analog monophosphate by human UMP/CMPK

The reactions were performed at 37°C in the presence of 1 mm MgATP and 750 μm phosphate acceptor. Calculations for relative Vmax, Km, and relative efficiency are as mentioned in Table 1. Activity for dCMP phosphorylation was 33 ± 4 μmol/mg/min. Values are presented as mean ± SD from three independent experiments.

Phosphate acceptorRelative Vmax (%)Kmm)Relative efficiency (%)
dCMP 100 500 ± 34 100 
AraCMP 827 ± 19 917 ± 83 451 
Gemcitabine monophosphate 94 ± 10 581 ± 25 81 
d-ddCMP 10 ± 2 272 ± 53 18 
l-ddCMP 19 ± 3 697 ± 72 13 
l-(−)-OddCMPa 19 ± 3 1037 ± 52 
l-(−)-SddCMP 92 ± 10 494 ± 94 93 
l-(−)-FSddCMP 9 ± 2 250 ± 62 18 
l-(−)-Fd4CMP 9 ± 2 228 ± 68 19 
Phosphate acceptorRelative Vmax (%)Kmm)Relative efficiency (%)
dCMP 100 500 ± 34 100 
AraCMP 827 ± 19 917 ± 83 451 
Gemcitabine monophosphate 94 ± 10 581 ± 25 81 
d-ddCMP 10 ± 2 272 ± 53 18 
l-ddCMP 19 ± 3 697 ± 72 13 
l-(−)-OddCMPa 19 ± 3 1037 ± 52 
l-(−)-SddCMP 92 ± 10 494 ± 94 93 
l-(−)-FSddCMP 9 ± 2 250 ± 62 18 
l-(−)-Fd4CMP 9 ± 2 228 ± 68 19 
a

l-(−)-OddCMP, β-l-dioxolane-CMP; l-(−)-Fd4CMP, β-l-2′,3′-dideoxy-2′,3′-didehydro-5-fluoro-CMP.

Close Modal

or Create an Account

Close Modal
Close Modal